‘When I started in IR, I told my wife I would stay in the job for five years – no more,’ says Dr Karl Mahler, who not only stuck with the profession but led the investor relations program at pharmaceuticals giant Roche for 20 years before (semi) retiring this year. During that time, he has won multiple IR awards for his work, pioneered ESG reporting and nurtured a host of IR talent, with former members of his team going on to run IR programs everywhere from AstraZeneca to Twitter.
Like many, Mahler moved into IR after simply finding that his particular . . .
Enjoy access to this and more – for free!
Log in or create your free My IR – Essentials account to:
- Get access to 3 free IR deep dives
- More than 100 pieces of insight, plus our exclusive CFO interviews
- Save favorites and get personalized content on your dashboard
- Enjoy 10% off all IR forums
